Terms: = Breast cancer AND AKAP9, AKAP350, 10142, ENSG00000127914, KIAA0803, Q99996, AKAP450, YOTIAO, PRKA9, HYPERION, MU-RMS-40_16A, CG-NAP
46 results:
1. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFR
Raghunath Khedkar N; Sindkhedkar M; Joseph A
Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682
[TBL] [Abstract] [Full Text] [Related]
2. Design, synthesis, and biological evaluation of furan-bearing pyrazolo[3,4-b]pyridines as novel inhibitors of CDK2 and P53-MDM2 protein-protein interaction.
Ezzat MAF; Elmasry GF; El-Mageed MMAA; Fouad MA; Abdel-Aziz HA; Elewa SI
Drug Dev Res; 2023 Sep; 84(6):1183-1203. PubMed ID: 37191966
[TBL] [Abstract] [Full Text] [Related]
3. Design, Synthesis, and Antiproliferative Activity of Novel Neocryptolepine-Rhodanine Hybrids.
El-Bahnsawye M; Hussein MKA; Elmongy EI; Awad HM; Tolan AAE; Moemen YS; El-Shaarawy A; El-Sayed IE
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364427
[TBL] [Abstract] [Full Text] [Related]
4. TITAN: An end-to-end data analysis environment for the hyperion™ imaging system.
Thirumal S; Jamzad A; Cotechini T; Hindmarch CT; Graham CH; Siemens DR; Mousavi P
Cytometry A; 2022 May; 101(5):423-433. PubMed ID: 35060322
[TBL] [Abstract] [Full Text] [Related]
5. Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
Liang JJ; Yu WL; Yang L; Xie BH; Qin KM; Yin YP; Yan JJ; Gong S; Liu TY; Zhou HB; Hong K
Eur J Med Chem; 2022 Feb; 229():114081. PubMed ID: 34992039
[TBL] [Abstract] [Full Text] [Related]
6. Activation of TMEM16A Ca
Luo S; Wang H; Bai L; Chen Y; Chen S; Gao K; Wang H; Wu S; Song H; Ma K; Liu M; Yao F; Fang Y; Xiao Q
J Adv Res; 2021 Nov; 33():253-264. PubMed ID: 34603794
[TBL] [Abstract] [Full Text] [Related]
7. Synthesis and biological screening of new thiadiazolopyrimidine-based polycyclic compounds.
Alqahtani AM
Sci Rep; 2021 Aug; 11(1):15750. PubMed ID: 34344971
[TBL] [Abstract] [Full Text] [Related]
8. Synthesis and cytotoxic evaluation of novel hybrid estrane heterocycles as chemotherapeutic anti-cancer agents.
Nada DS; Elkady DS; Elsayed GH; A-H Abdel-Rahman A; Elmegeed GA
Steroids; 2021 May; 169():108813. PubMed ID: 33652007
[TBL] [Abstract] [Full Text] [Related]
9. Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences.
Priedigkeit N; Ding K; Horne W; Kolls JK; Du T; Lucas PC; Blohmer JU; Denkert C; Machleidt A; Ingold-Heppner B; Oesterreich S; Lee AV
Breast Cancer Res; 2021 Jan; 23(1):1. PubMed ID: 33407744
[TBL] [Abstract] [Full Text] [Related]
10. Design, synthesis and cytotoxic evaluation of truncated 3'-deoxy- 3', 3' difluororibofuranosyl pyrimidine nucleosides.
Sivakrishna B; Shukla M; Santra MK; Pal S
Carbohydr Res; 2020 Nov; 497():108113. PubMed ID: 32858257
[TBL] [Abstract] [Full Text] [Related]
11. An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications.
Dasgupta A; Chen KH; Wu D; Hoskin V; Mewburn J; Lima PDA; Parlow LRG; Hindmarch CCT; Martin A; Sykes EA; Tayade C; Lightbody ED; Madarnas Y; SenGupta SK; Elliott BE; Nicol CJB; Archer SL
FASEB J; 2020 Apr; 34(4):5106-5127. PubMed ID: 32068312
[TBL] [Abstract] [Full Text] [Related]
12.
Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis.
Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
Cancer Lett; 2019 Oct; 461():65-77. PubMed ID: 31319138
[TBL] [Abstract] [Full Text] [Related]
14. Structure-activity relationships and evaluation of esterified diterpenoid alkaloid derivatives as antiproliferative agents.
Wada K; Goto M; Shimizu T; Kusanagi N; Mizukami M; Suzuki Y; Li KP; Lee KH; Yamashita H
J Nat Med; 2019 Sep; 73(4):789-799. PubMed ID: 31222559
[TBL] [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors.
Yamashita M; Tahara T; Hayakawa S; Matsumoto H; Wada SI; Tomioka K; Iida A
Bioorg Med Chem; 2018 May; 26(8):1920-1928. PubMed ID: 29519604
[TBL] [Abstract] [Full Text] [Related]
16. Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.
Fujii S; Nakamura S; Oda A; Miki H; Tenshin H; Teramachi J; Hiasa M; Bat-Erdene A; Maeda Y; Oura M; Takahashi M; Iwasa M; Endo I; Yoshida S; Aihara KI; Kurahashi K; Harada T; Kagawa K; Nakao M; Sano S; Abe M
Br J Haematol; 2018 Jan; 180(2):246-258. PubMed ID: 29327347
[TBL] [Abstract] [Full Text] [Related]
17. A Metabolomics Analysis of Body Mass Index and Postmenopausal breast cancer Risk.
Moore SC; Playdon MC; Sampson JN; Hoover RN; Trabert B; Matthews CE; Ziegler RG
J Natl Cancer Inst; 2018 Jun; 110(6):588-597. PubMed ID: 29325144
[TBL] [Abstract] [Full Text] [Related]
18. Syntheses of conformationally restricted benzopyran based triarylethylenes as growth inhibitors of carcinoma cells.
Ahmad MI; Dixit S; Konwar R; Vasdev PG; Yadav AK; Tripathi S; Gupta MM; Sharma A; Gupta A
Bioorg Med Chem Lett; 2017 Nov; 27(22):5040-5045. PubMed ID: 29054359
[TBL] [Abstract] [Full Text] [Related]
19. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL
Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents.
Gupta N; Rath SK; Singh J; Qayum A; Singh S; Sangwan PL
Eur J Med Chem; 2017 Jul; 135():517-530. PubMed ID: 28500966
[TBL] [Abstract] [Full Text] [Related]
[Next]
